Visiting professor lecture: Simon Goodman

Date/Time
Date(s) - 12/10/2021
3:00 pm - 4:00 pm

Date/Time
Date(s) – 12/10/2021
15:00 am – 16:00 pm

October 12th at 15:00

Professor Simon Goodman, Science and Technology Program Manager, the Antibody Society, Germany

Integrins as drug targets

.

Register latest Sunday October 10th  

https://link.webropol.com/s/VP-Simon-Goodman

.

Professor Goodman will be holding his a lecture about the topic of Integrins as drug targets in the Medisiina D Lecture Hall Lauren 1 on Tuesday October 12th  at 15:15. We welcome everybody to come and listen! The lecture can also be attended via zoom connection (no registration required):

https://utu.zoom.us/j/61710469294

.

Simon L. Goodman

Simon is Science and Technology Program Manager for the Antibody Society. He gained his D.Phil in membrane biochemistry from the University of Sussex. His start-up biotechnology company works on antibody validation.  He spent many years at Merck inventing and developing peptide and antibody therapeutics targeting cell adhesion through phase 3 clinical trials in oncology. Prior to Merck, he did post-doctoral work at Max-Planck Society on cellular receptors for laminin, with Klaus von der Mark at Martinsried, Munich and Erlangen, and phenotypic antibody screens with Walter Birchmeier at MPI Tübingen. His work includes the first high resolution X-ray structures of integrins, in collaboration with Dr. Amin Arnaout (Harvard Medical School).  His career in academia and industry has resulted in over 100 peer-reviewed publications, reviews and in many patents.